Skip to main content
Mabpharm Limited logo

Mabpharm Limited — Investor Relations & Filings

Ticker · 2181 ISIN · KYG5780F1046 HKEX Manufacturing
Open in API
Filings indexed 221 across all filing types
Latest filing 2019-05-30 Governance Information
Country HK Hong Kong
Listing HKEX 2181

About Mabpharm Limited

http://www.mabpharm.cn

Mabpharm Limited is a biopharmaceutical company focused on the research, development, production, and commercialization of monoclonal antibody (mAb) drugs and biosimilars. The core therapeutic areas include oncology (cancer) and autoimmune diseases. The company emphasizes bringing high-quality, affordable, and innovative biological drugs to the market by utilizing efficient R&D systems and low-cost manufacturing capabilities. Its robust pipeline features multiple candidates, including 9 monoclonal antibody drugs and 1 strong antibody drug.

Recent filings

Filing Released Lang Actions
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is titled 'Amended and Restated Memorandum and Articles of Association' of Mabpharm Limited, adopted by special resolution and effective upon listing on the Hong Kong Stock Exchange. It contains detailed company constitutional documents including objects, share capital, board structure, shareholder rights, and governance provisions. This is a governance-related document outlining the internal rules and structure of the company rather than a financial report, announcement, or regulatory filing. It is not an annual report, interim report, earnings release, or any other financial or capital market update. The content aligns with Governance Information filings, which cover company internal rules, board structure, and governance practices.
2019-05-30 English
GLOBAL OFFERING - ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement of IPO allotment results for MABPHARM LIMITED. It provides links to various PDF files containing the specific results of share applications (White/Yellow forms, CCASS instructions). Since this document serves as a notification and index for the publication of these allotment results rather than being the full financial report or a specific regulatory filing category like 'SHA' (which usually refers to capital changes for existing listed entities), it is best classified as a Regulatory Filing (RNS) as it pertains to the IPO process and disclosure of allotment outcomes.
2019-05-30 English
Green Application Form
Capital/Financing Update Classification · 95% confidence The document is an application form for a Hong Kong public offering of shares by Mabpharm Limited. It includes detailed instructions and declarations related to the subscription of shares in the global offering, references to the prospectus, and compliance with regulatory requirements for the offering. There is no financial performance data, management discussion, or audit information. It is not a report or announcement of financial results, nor a regulatory filing about management or governance changes. The content is clearly related to the capital raising process through a public offering of shares. Therefore, the document fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2019-05-20 English
Yellow Application Form
Share Issue/Capital Change Classification · 95% confidence The document is an application form related to the issuance of Hong Kong Offer Shares for Mabpharm Limited, referencing the company's prospectus dated May 20, 2019. It contains detailed instructions on how to apply for shares, payment calculations, and declarations by applicants. The text is clearly related to a share issuance process and includes terms like "Hong Kong Offer Shares," "application form," and references to the prospectus and offer price. There is no indication that this is a report or announcement of financial results, management changes, or regulatory filings. Instead, it is a form used by investors to apply for shares in a new offering. Therefore, this document fits the category of a Share Issue/Capital Change announcement or related document.
2019-05-20 English
White Application Form
Capital/Financing Update Classification · 95% confidence The document is an application form related to the issuance of Hong Kong Offer Shares for Mabpharm Limited, referencing a prospectus dated May 20, 2019. It contains detailed instructions on how to apply for shares, payment details, and legal disclaimers about the offer. There is no financial performance data, management discussion, or regulatory certification. The document is clearly related to a capital raising event, specifically a public offering of shares. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2019-05-20 English
GLOBAL OFFERING
Regulatory Filings
2019-05-20 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.